Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded North Carolina under the new Locations section. Removed the HHS Vulnerability Disclosure item from the footer; page revision updated to v3.3.3.SummaryDifference0.2%

- Check52 days agoChange Detected- Added collaborator: C. R. Bard; removed collaborator: CareFusion. - Page revision updated to v3.3.2.SummaryDifference0.1%

- Check59 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1; no changes to study data or page navigation.SummaryDifference0.1%

- Check67 days agoChange DetectedThe general funding-related operating status notice has been removed from the page, removing a warning that information may be out of date and that some website functions may not be processed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.